CIBC World Market’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $686K | Buy |
14,109
+2,785
| +25% | +$135K | ﹤0.01% | 891 |
|
|
2025
Q1 | $385K | Buy |
11,324
+2,598
| +30% | +$88.4K | ﹤0.01% | 1019 |
|
|
2024
Q4 | $343K | Sell |
8,726
-2,638
| -23% | -$104K | ﹤0.01% | 1054 |
|
|
2024
Q3 | $534K | Sell |
11,364
-1,135
| -9% | -$53.3K | ﹤0.01% | 895 |
|
|
2024
Q2 | $675K | Sell |
12,499
-777
| -6% | -$42K | ﹤0.01% | 813 |
|
|
2024
Q1 | $905K | Sell |
13,276
-414
| -3% | -$28.2K | ﹤0.01% | 770 |
|
|
2023
Q4 | $857K | Buy |
13,690
+3,439
| +34% | +$215K | ﹤0.01% | 721 |
|
|
2023
Q3 | $465K | Buy |
10,251
+1,095
| +12% | +$49.7K | ﹤0.01% | 837 |
|
|
2023
Q2 | $514K | Sell |
9,156
-198
| -2% | -$11.1K | ﹤0.01% | 830 |
|
|
2023
Q1 | $423K | Buy |
9,354
+410
| +5% | +$18.5K | ﹤0.01% | 893 |
|
|
2022
Q4 | $364K | Sell |
8,944
-17
| -0.2% | -$692 | ﹤0.01% | 897 |
|
|
2022
Q3 | $586K | Sell |
8,961
-417
| -4% | -$27.3K | ﹤0.01% | 760 |
|
|
2022
Q2 | $570K | Buy |
9,378
+1,024
| +12% | +$62.2K | ﹤0.01% | 782 |
|
|
2022
Q1 | $524K | Buy |
8,354
+2,760
| +49% | +$173K | ﹤0.01% | 875 |
|
|
2021
Q4 | $424K | Sell |
5,594
-840
| -13% | -$63.7K | ﹤0.01% | 957 |
|
|
2021
Q3 | $720K | Sell |
6,434
-5,244
| -45% | -$587K | ﹤0.01% | 815 |
|
|
2021
Q2 | $1.89M | Buy |
11,678
+7,472
| +178% | +$1.21M | 0.01% | 560 |
|
|
2021
Q1 | $513K | Buy |
4,206
+1,954
| +87% | +$238K | ﹤0.01% | 895 |
|
|
2020
Q4 | $345K | Buy |
+2,252
| New | +$345K | ﹤0.01% | 971 |
|
|
2018
Q3 | – | Sell |
-14,028
| Closed | -$824K | – | 1099 |
|
|
2018
Q2 | $824K | Sell |
14,028
-11,270
| -45% | -$662K | ﹤0.01% | 694 |
|
|
2018
Q1 | $1.16M | Buy |
+25,298
| New | +$1.16M | ﹤0.01% | 560 |
|